id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02561104
|
41:65:chronic_disease,70:86:chronic_disease,98:135:treatment
|
History of lens abnormalities including posterior polar cataract and zonular weakness precluding standard non‐complex cataract surgery
| 1
|
[
"History",
"of",
"lens",
"abnormalities",
"including",
"posterior",
"polar",
"cataract",
"and",
"zonular",
"weakness",
"precluding",
"standard",
"non‐complex",
"cataract",
"surgery"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
1,
1,
1,
1
] |
NCT02555189
|
,,,120:129:treatment,
|
Sexually active males unless they use a condom during intercourse while taking the drug and for 30 days after stopping treatment and should not father a child in this period. A condom is required to be used by vasectomized men in order to prevent delivery of the drug via seminal fluid
| 1
|
[
"Sexually",
"active",
"males",
"unless",
"they",
"use",
"a",
"condom",
"during",
"intercourse",
"while",
"taking",
"the",
"drug",
"and",
"for",
"30",
"days",
"after",
"stopping",
"treatment",
"and",
"should",
"not",
"father",
"a",
"child",
"in",
"this",
"period",
".",
"A",
"condom",
"is",
"required",
"to",
"be",
"used",
"by",
"vasectomized",
"men",
"in",
"order",
"to",
"prevent",
"delivery",
"of",
"the",
"drug",
"via",
"seminal",
"fluid"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02461927
|
1:28:chronic_disease
|
Acute narrow-angle glaucoma
| 1
|
[
"Acute",
"narrow-angle",
"glaucoma"
] |
[
2,
2,
2
] |
NCT01419561
|
5:8:chronic_disease
|
Any HIV status
| 1
|
[
"Any",
"HIV",
"status"
] |
[
0,
2,
0
] |
NCT02132130
|
33:47:chronic_disease,49:62:chronic_disease,64:93:chronic_disease,128:144:treatment,148:165:treatment
|
Any otological history, such as chronic otitis, cholesteatoma, tympanic membrane perforation, that suggests poor candidacy for cochlear implant or inner ear surgery or suggests potential interference with study auditory or vestibular function tests
| 1
|
[
"Any",
"otological",
"history",
",",
"such",
"as",
"chronic",
"otitis",
",",
"cholesteatoma",
",",
"tympanic",
"membrane",
"perforation",
",",
"that",
"suggests",
"poor",
"candidacy",
"for",
"cochlear",
"implant",
"or",
"inner",
"ear",
"surgery",
"or",
"suggests",
"potential",
"interference",
"with",
"study",
"auditory",
"or",
"vestibular",
"function",
"tests"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01896999
|
,,113:122:treatment
|
vaccines are not prohibited on study, but must be given at least 6 weeks after cycle 1 and not within 7 days of treatment
| 1
|
[
"vaccines",
"are",
"not",
"prohibited",
"on",
"study",
",",
"but",
"must",
"be",
"given",
"at",
"least",
"6",
"weeks",
"after",
"cycle",
"1",
"and",
"not",
"within",
"7",
"days",
"of",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02359825
|
12:24:treatment
|
undergoing chemotherapy
| 1
|
[
"undergoing",
"chemotherapy"
] |
[
0,
1
] |
NCT02464969
|
22:25:chronic_disease
|
Presence of an index VTE which is confirmed by imaging
| 1
|
[
"Presence",
"of",
"an",
"index",
"VTE",
"which",
"is",
"confirmed",
"by",
"imaging"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02516241
|
25:53:treatment,,94:122:treatment,174:184:treatment,186:193:treatment,195:211:treatment,216:240:treatment,246:271:treatment,275:299:treatment,303:320:treatment,,348:358:treatment,379:387:treatment,441:462:treatment
|
Current or prior use of immunosuppressive medication within 14 days before the first dose of investigational product (IP). The following are exceptions to this criterion: • Intranasal, inhaled, topical steroids, or local steroid injections (eg, intra articular injection) • Systemic corticosteroids at physiologic doses not to exceed 10 mg/day of prednisone or its equivalent • Steroids as premedication for hypersensitivity reactions (eg, CT scan premedication)
| 1
|
[
"Current",
"or",
"prior",
"use",
"of",
"immunosuppressive",
"medication",
"within",
"14",
"days",
"before",
"the",
"first",
"dose",
"of",
"investigational",
"product",
"(",
"IP",
")",
".",
"The",
"following",
"are",
"exceptions",
"to",
"this",
"criterion",
":",
"•",
"Intranasal",
",",
"inhaled",
",",
"topical",
"steroids",
",",
"or",
"local",
"steroid",
"injections",
"(",
"eg",
",",
"intra",
"articular",
"injection",
")",
"•",
"Systemic",
"corticosteroids",
"at",
"physiologic",
"doses",
"not",
"to",
"exceed",
"10",
"mg/day",
"of",
"prednisone",
"or",
"its",
"equivalent",
"•",
"Steroids",
"as",
"premedication",
"for",
"hypersensitivity",
"reactions",
"(",
"eg",
",",
"CT",
"scan",
"premedication",
")"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0
] |
NCT03056339
|
,,60:80:chronic_disease,101:105:treatment,109:113:treatment
|
Cardiac: Cardiac ejection fraction >/= 50%, no evidence of pericardial effusion as determined by an ECHO or MUGA, and no clinically significant ECG findings
| 1
|
[
"Cardiac",
":",
"Cardiac",
"ejection",
"fraction",
">",
"/=",
"50",
"%",
",",
"no",
"evidence",
"of",
"pericardial",
"effusion",
"as",
"determined",
"by",
"an",
"ECHO",
"or",
"MUGA",
",",
"and",
"no",
"clinically",
"significant",
"ECG",
"findings"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03000257
|
19:56:chronic_disease
|
participants with chronic or active hepatitis A, B or C
| 1
|
[
"participants",
"with",
"chronic",
"or",
"active",
"hepatitis",
"A",
",",
"B",
"or",
"C"
] |
[
0,
0,
2,
2,
2,
2,
2,
2,
2,
2,
0
] |
NCT02498951
|
1:39:treatment,
|
Brain magnetic resonance imaging (MRI) documenting CR must be obtained within 30 days of study enrollment
| 1
|
[
"Brain",
"magnetic",
"resonance",
"imaging",
"(",
"MRI",
")",
"documenting",
"CR",
"must",
"be",
"obtained",
"within",
"30",
"days",
"of",
"study",
"enrollment"
] |
[
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02554786
|
33:43:treatment
|
have not achieved an acceptable spirometry results at Visit 101 in accordance with American Thoracic Society/European Respiratory Society (ATS/ERS) criteria for acceptability and repeatability (rescreening allowed only once)
| 1
|
[
"have",
"not",
"achieved",
"an",
"acceptable",
"spirometry",
"results",
"at",
"Visit",
"101",
"in",
"accordance",
"with",
"American",
"Thoracic",
"Society/European",
"Respiratory",
"Society",
"(",
"ATS/ERS",
")",
"criteria",
"for",
"acceptability",
"and",
"repeatability",
"(",
"rescreening",
"allowed",
"only",
"once",
")"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02465034
|
10:18:chronic_disease,
|
Signs of dementia (score < 24 on the Montreal Cognitive Assessment)
| 1
|
[
"Signs",
"of",
"dementia",
"(",
"score",
"<",
"24",
"on",
"the",
"Montreal",
"Cognitive",
"Assessment",
")"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02464904
|
,,23:35:chronic_disease,,
|
Platelet count < 50K, coagulopathy defined as an International Normalized Ratio (INR) > 1.5
| 1
|
[
"Platelet",
"count",
"<",
"50K",
",",
"coagulopathy",
"defined",
"as",
"an",
"International",
"Normalized",
"Ratio",
"(",
"INR",
")",
">",
"1.5"
] |
[
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01430390
|
20:35:treatment,39:64:treatment,,179:188:treatment,192:201:treatment
|
Subjects receiving steroid therapy at physiological replacement doses only are allowed provided there has been no increase in dose for at least 2 weeks prior to subject starting apheresis or treatment
| 1
|
[
"Subjects",
"receiving",
"steroid",
"therapy",
"at",
"physiological",
"replacement",
"doses",
"only",
"are",
"allowed",
"provided",
"there",
"has",
"been",
"no",
"increase",
"in",
"dose",
"for",
"at",
"least",
"2",
"weeks",
"prior",
"to",
"subject",
"starting",
"apheresis",
"or",
"treatment"
] |
[
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT02905591
|
42:48:treatment,50:61:treatment,63:75:treatment,82:108:cancer
|
Pathologic diagnosis (i.e., cell sample, biopsy, tissue swap, bronchoscopy) with non-small cell lung cancer
| 1
|
[
"Pathologic",
"diagnosis",
"(",
"i.e.",
",",
"cell",
"sample",
",",
"biopsy",
",",
"tissue",
"swap",
",",
"bronchoscopy",
")",
"with",
"non-small",
"cell",
"lung",
"cancer"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
0,
0,
3,
3,
3,
3
] |
NCT02565199
|
4:24:chronic_disease
|
No neurological disease
| 1
|
[
"No",
"neurological",
"disease"
] |
[
0,
2,
2
] |
NCT01087294
|
,,90:100:cancer
|
Platelet count less than 30,000/microL unless low platelet count is thought to be due to malignancy in the bone marrow and malignancy is documented in the bone marrow
| 1
|
[
"Platelet",
"count",
"less",
"than",
"30,000/microL",
"unless",
"low",
"platelet",
"count",
"is",
"thought",
"to",
"be",
"due",
"to",
"malignancy",
"in",
"the",
"bone",
"marrow",
"and",
"malignancy",
"is",
"documented",
"in",
"the",
"bone",
"marrow"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02514083
|
10:26:chronic_disease
|
Impaired hepatic function
| 1
|
[
"Impaired",
"hepatic",
"function"
] |
[
0,
2,
2
] |
NCT01953900
|
7:32:chronic_disease
|
Known primary immune deficiency
| 1
|
[
"Known",
"primary",
"immune",
"deficiency"
] |
[
0,
2,
2,
2
] |
NCT02503358
|
,,,86:95:treatment
|
Known actionable mutations (e.g., EGFR, ALK, ROS1), against which there is available treatment
| 1
|
[
"Known",
"actionable",
"mutations",
"(",
"e.g.",
",",
"EGFR",
",",
"ALK",
",",
"ROS1",
")",
",",
"against",
"which",
"there",
"is",
"available",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03146663
|
,27:50:treatment
|
Received at least 3 prior chemotherapy-containing regimens
| 1
|
[
"Received",
"at",
"least",
"3",
"prior",
"chemotherapy-containing",
"regimens"
] |
[
0,
0,
0,
0,
0,
1,
0
] |
NCT02367040
|
18:62:chronic_disease
|
Known history of human immunodeficiency virus (HIV) infection
| 1
|
[
"Known",
"history",
"of",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"infection"
] |
[
0,
0,
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT01811498
|
50:73:chronic_disease
|
Patients with documented histologic diagnosis of glioblastoma multiforme (newly diagnosed)
| 1
|
[
"Patients",
"with",
"documented",
"histologic",
"diagnosis",
"of",
"glioblastoma",
"multiforme",
"(",
"newly",
"diagnosed",
")"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02519322
|
,,,,,248:257:treatment
|
subjects with TnT or TnI levels between > 1 to 2 x ULN will be permitted if repeat levels within 24 hours are </= 1 x ULN; if TnT or TnI levels are > 1 to 2 x ULN within 24 hours, the subject may undergo a cardiac evaluation and be considered for treatment, following a discussion with the investigator or designee
| 1
|
[
"subjects",
"with",
"TnT",
"or",
"TnI",
"levels",
"between",
">",
"1",
"to",
"2",
"x",
"ULN",
"will",
"be",
"permitted",
"if",
"repeat",
"levels",
"within",
"24",
"hours",
"are",
"<",
"/=",
"1",
"x",
"ULN",
";",
"if",
"TnT",
"or",
"TnI",
"levels",
"are",
">",
"1",
"to",
"2",
"x",
"ULN",
"within",
"24",
"hours",
",",
"the",
"subject",
"may",
"undergo",
"a",
"cardiac",
"evaluation",
"and",
"be",
"considered",
"for",
"treatment",
",",
"following",
"a",
"discussion",
"with",
"the",
"investigator",
"or",
"designee"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02802176
|
1:68:chronic_disease
|
Vaginal inflammation or genital (vaginal, uterine, tubal) infection
| 1
|
[
"Vaginal",
"inflammation",
"or",
"genital",
"(",
"vaginal",
",",
"uterine",
",",
"tubal",
")",
"infection"
] |
[
2,
2,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT02401035
|
8:18:cancer
|
Active malignancy of any type, or history of a malignancy
| 1
|
[
"Active",
"malignancy",
"of",
"any",
"type",
",",
"or",
"history",
"of",
"a",
"malignancy"
] |
[
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02365467
|
,,215:244:treatment
|
Subject has circumferential calcification in the external iliac artery or in the common iliac artery with an intraluminal diameter (ID) less than 10mm at any point proximal to or at the access vessel site unless a surgical adjunctive procedure is planned
| 1
|
[
"Subject",
"has",
"circumferential",
"calcification",
"in",
"the",
"external",
"iliac",
"artery",
"or",
"in",
"the",
"common",
"iliac",
"artery",
"with",
"an",
"intraluminal",
"diameter",
"(",
"ID",
")",
"less",
"than",
"10mm",
"at",
"any",
"point",
"proximal",
"to",
"or",
"at",
"the",
"access",
"vessel",
"site",
"unless",
"a",
"surgical",
"adjunctive",
"procedure",
"is",
"planned"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0
] |
NCT01754298
|
1:13:treatment
|
chemotherapy treatment
| 1
|
[
"chemotherapy",
"treatment"
] |
[
1,
0
] |
NCT01827384
|
15:30:cancer,44:57:treatment,61:72:treatment
|
patients with prostate cancer may continue LHRH agonists or antagonists
| 1
|
[
"patients",
"with",
"prostate",
"cancer",
"may",
"continue",
"LHRH",
"agonists",
"or",
"antagonists"
] |
[
0,
0,
3,
3,
0,
0,
1,
1,
0,
1
] |
NCT02570984
|
12:24:chronic_disease
|
history of tuberculosis
| 1
|
[
"history",
"of",
"tuberculosis"
] |
[
0,
0,
2
] |
NCT02140255
|
10:13:chronic_disease
|
Presumed HIV infection defined as greater than or equal to one positive rapid HIV antibody test obtained in the peripartum period
| 1
|
[
"Presumed",
"HIV",
"infection",
"defined",
"as",
"greater",
"than",
"or",
"equal",
"to",
"one",
"positive",
"rapid",
"HIV",
"antibody",
"test",
"obtained",
"in",
"the",
"peripartum",
"period"
] |
[
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02148263
|
1:18:treatment,
|
Topical eye drops within the last two hours of the study visit
| 1
|
[
"Topical",
"eye",
"drops",
"within",
"the",
"last",
"two",
"hours",
"of",
"the",
"study",
"visit"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02278315
|
,38:56:treatment
|
Grade 2 or greater toxicities due to previous therapies, subject to laboratory abnormalities listed below
| 1
|
[
"Grade",
"2",
"or",
"greater",
"toxicities",
"due",
"to",
"previous",
"therapies",
",",
"subject",
"to",
"laboratory",
"abnormalities",
"listed",
"below"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02416206
|
,43:55:treatment
|
Within 9 months of the start of induction chemotherapy and no evidence of relapse or progression
| 1
|
[
"Within",
"9",
"months",
"of",
"the",
"start",
"of",
"induction",
"chemotherapy",
"and",
"no",
"evidence",
"of",
"relapse",
"or",
"progression"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02624258
|
69:88:allergy_name,90:94:allergy_name,100:110:allergy_name
|
History of allergy or hypersensitivity to study product excipients (human serum albumin, DMSO, and Dextran 40)
| 1
|
[
"History",
"of",
"allergy",
"or",
"hypersensitivity",
"to",
"study",
"product",
"excipients",
"(",
"human",
"serum",
"albumin",
",",
"DMSO",
",",
"and",
"Dextran",
"40",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
4,
4,
0,
4,
0,
0,
4,
4,
0
] |
NCT02016924
|
27:30:chronic_disease
|
individuals with positive HCV antibody and without detectable HCV RNA are permitted to enroll
| 1
|
[
"individuals",
"with",
"positive",
"HCV",
"antibody",
"and",
"without",
"detectable",
"HCV",
"RNA",
"are",
"permitted",
"to",
"enroll"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02724930
|
1:9:chronic_disease
|
dementia
| 1
|
[
"dementia"
] |
[
2
] |
NCT02216227
|
46:58:chronic_disease
|
Have an ICD-9 diagnosis code consistent with endocarditis
| 1
|
[
"Have",
"an",
"ICD-9",
"diagnosis",
"code",
"consistent",
"with",
"endocarditis"
] |
[
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02553642
|
33:53:treatment
|
The lesion being considered for palliative radiation is not a target lesion
| 1
|
[
"The",
"lesion",
"being",
"considered",
"for",
"palliative",
"radiation",
"is",
"not",
"a",
"target",
"lesion"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02207439
|
1:19:treatment,
|
Prior chemotherapy within the past 5 years
| 1
|
[
"Prior",
"chemotherapy",
"within",
"the",
"past",
"5",
"years"
] |
[
1,
1,
0,
0,
0,
0,
0
] |
NCT02424968
|
24:35:chronic_disease
|
donors with a positive hepatitis B PCR test
| 1
|
[
"donors",
"with",
"a",
"positive",
"hepatitis",
"B",
"PCR",
"test"
] |
[
0,
0,
0,
0,
2,
2,
0,
0
] |
NCT01884740
|
32:39:treatment
|
Because of known concerns with Avastin and wound healing
| 1
|
[
"Because",
"of",
"known",
"concerns",
"with",
"Avastin",
"and",
"wound",
"healing"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02041936
|
19:27:chronic_disease,31:49:chronic_disease,51:57:chronic_disease,61:85:chronic_disease
|
Have a history of epilepsy or cardiac arrhythmia (atrial or ventricular fibrillation)
| 1
|
[
"Have",
"a",
"history",
"of",
"epilepsy",
"or",
"cardiac",
"arrhythmia",
"(",
"atrial",
"or",
"ventricular",
"fibrillation",
")"
] |
[
0,
0,
0,
0,
2,
0,
2,
2,
0,
2,
0,
2,
2,
0
] |
NCT02397083
|
30:50:treatment,62:74:treatment,76:93:treatment,95:103:treatment,108:130:treatment
|
Patients currently receiving anticancer therapies (including chemotherapy, radiation therapy, hormonal, or antibody-based therapy)
| 1
|
[
"Patients",
"currently",
"receiving",
"anticancer",
"therapies",
"(",
"including",
"chemotherapy",
",",
"radiation",
"therapy",
",",
"hormonal",
",",
"or",
"antibody-based",
"therapy",
")"
] |
[
0,
0,
0,
1,
1,
0,
0,
1,
0,
1,
1,
0,
1,
0,
0,
1,
1,
0
] |
NCT02343042
|
14:33:chronic_disease
|
Known active hepatitis A, B or C
| 1
|
[
"Known",
"active",
"hepatitis",
"A",
",",
"B",
"or",
"C"
] |
[
0,
0,
2,
2,
2,
2,
2,
0
] |
NCT01943851
|
,56:66:treatment
|
any subject who is expected to require a QT prolonging medication while on trial should not be enrolled
| 1
|
[
"any",
"subject",
"who",
"is",
"expected",
"to",
"require",
"a",
"QT",
"prolonging",
"medication",
"while",
"on",
"trial",
"should",
"not",
"be",
"enrolled"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03151434
|
18:28:treatment
|
Desires Regional anesthesia for postoperative pain control
| 1
|
[
"Desires",
"Regional",
"anesthesia",
"for",
"postoperative",
"pain",
"control"
] |
[
0,
0,
1,
0,
0,
0,
0
] |
NCT02130388
|
1:5:chronic_disease,,
|
AIDS defining illness or Cluster of Differentiation 4 < 200
| 1
|
[
"AIDS",
"defining",
"illness",
"or",
"Cluster",
"of",
"Differentiation",
"4",
"<",
"200"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03105362
|
40:57:chronic_disease
|
Patients with a primary diagnosis of a motility disorder
| 1
|
[
"Patients",
"with",
"a",
"primary",
"diagnosis",
"of",
"a",
"motility",
"disorder"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02013778
|
1:11:treatment
|
Prior TACE
| 1
|
[
"Prior",
"TACE"
] |
[
1,
1
] |
NCT02390752
|
1:30:treatment,,72:101:treatment,120:131:treatment
|
Myelosuppressive chemotherapy: At least 21 days after the last dose of myelosuppressive chemotherapy (42 days if prior nitrosourea)
| 1
|
[
"Myelosuppressive",
"chemotherapy",
":",
"At",
"least",
"21",
"days",
"after",
"the",
"last",
"dose",
"of",
"myelosuppressive",
"chemotherapy",
"(",
"42",
"days",
"if",
"prior",
"nitrosourea",
")"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0
] |
NCT02134392
|
12:22:cancer
|
History of malignancy
| 1
|
[
"History",
"of",
"malignancy"
] |
[
0,
0,
3
] |
NCT02513225
|
32:47:chronic_disease,
|
Severe risk for suicide (i.e., suicide attempt within past 6 months)
| 1
|
[
"Severe",
"risk",
"for",
"suicide",
"(",
"i.e.",
",",
"suicide",
"attempt",
"within",
"past",
"6",
"months",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02108860
|
10:53:treatment,72:84:treatment,88:103:treatment,116:141:treatment
|
Positive anti-neutrophil cytoplasmic antibody (ANCA) test specific for proteinase-3 or myeloperoxidase measured by enzyme-linked immunoassay
| 1
|
[
"Positive",
"anti-neutrophil",
"cytoplasmic",
"antibody",
"(",
"ANCA",
")",
"test",
"specific",
"for",
"proteinase-3",
"or",
"myeloperoxidase",
"measured",
"by",
"enzyme-linked",
"immunoassay"
] |
[
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1
] |
NCT03053518
|
19:32:chronic_disease,34:48:chronic_disease,53:64:chronic_disease
|
have a history of heart disease, kidney disease, or retinopathy (to rule-out those with long-standing, undiagnosed T2D)
| 1
|
[
"have",
"a",
"history",
"of",
"heart",
"disease",
",",
"kidney",
"disease",
",",
"or",
"retinopathy",
"(",
"to",
"rule-out",
"those",
"with",
"long-standing",
",",
"undiagnosed",
"T2D",
")"
] |
[
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02809677
|
13:30:chronic_disease
|
symptoms of persistent asthma in children not on a daily controller medication
| 1
|
[
"symptoms",
"of",
"persistent",
"asthma",
"in",
"children",
"not",
"on",
"a",
"daily",
"controller",
"medication"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02504866
|
12:33:chronic_disease
|
History of uncontrolled diabetes
| 1
|
[
"History",
"of",
"uncontrolled",
"diabetes"
] |
[
0,
0,
2,
2
] |
NCT02492867
|
29:70:cancer
|
Patients with evidence of a malignant pleural or pericardial effusion
| 1
|
[
"Patients",
"with",
"evidence",
"of",
"a",
"malignant",
"pleural",
"or",
"pericardial",
"effusion"
] |
[
0,
0,
0,
0,
0,
3,
3,
3,
3,
3
] |
NCT02582827
|
1:14:treatment,,65:75:treatment,97:115:treatment,160:173:treatment
|
Major surgery within 6 weeks before the first administration of study drug; needle aspirations, bone marrow biopsy and other similar procedures are allowable; minor surgery may be allowable following discussion and approval by Medical Monitor
| 1
|
[
"Major",
"surgery",
"within",
"6",
"weeks",
"before",
"the",
"first",
"administration",
"of",
"study",
"drug",
";",
"needle",
"aspirations",
",",
"bone",
"marrow",
"biopsy",
"and",
"other",
"similar",
"procedures",
"are",
"allowable",
";",
"minor",
"surgery",
"may",
"be",
"allowable",
"following",
"discussion",
"and",
"approval",
"by",
"Medical",
"Monitor"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02607514
|
1:21:chronic_disease
|
neurologic disorders
| 1
|
[
"neurologic",
"disorders"
] |
[
2,
2
] |
NCT02512497
|
21:32:chronic_disease
|
Patient with active CNS disease
| 1
|
[
"Patient",
"with",
"active",
"CNS",
"disease"
] |
[
0,
0,
0,
2,
2
] |
NCT01494662
|
42:65:treatment
|
Cohort 3a will have participants with no prior lapatinib therapy
| 1
|
[
"Cohort",
"3a",
"will",
"have",
"participants",
"with",
"no",
"prior",
"lapatinib",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02532543
|
41:50:treatment
|
Previous enrollment or randomization of treatment in the present study
| 1
|
[
"Previous",
"enrollment",
"or",
"randomization",
"of",
"treatment",
"in",
"the",
"present",
"study"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT03180086
|
,36:45:treatment
|
women who have taken or are taking tamoxifen
| 1
|
[
"women",
"who",
"have",
"taken",
"or",
"are",
"taking",
"tamoxifen"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01925131
|
4:14:treatment,18:27:treatment,61:64:chronic_disease
|
No zidovudine or stavudine as part of cART Patients who are HIV+ and do not meet all of these criteria are not eligible for this study
| 1
|
[
"No",
"zidovudine",
"or",
"stavudine",
"as",
"part",
"of",
"cART",
"Patients",
"who",
"are",
"HIV+",
"and",
"do",
"not",
"meet",
"all",
"of",
"these",
"criteria",
"are",
"not",
"eligible",
"for",
"this",
"study"
] |
[
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02159495
|
39:52:treatment,
|
Non hematological toxicity related to prior therapy must either have returned to =< grade 2, baseline, or deemed irreversible
| 1
|
[
"Non",
"hematological",
"toxicity",
"related",
"to",
"prior",
"therapy",
"must",
"either",
"have",
"returned",
"to",
"=",
"<",
"grade",
"2",
",",
"baseline",
",",
"or",
"deemed",
"irreversible"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02446236
|
29:53:chronic_disease
|
Uncontrolled or symptomatic congestive heart failure
| 1
|
[
"Uncontrolled",
"or",
"symptomatic",
"congestive",
"heart",
"failure"
] |
[
0,
0,
0,
2,
2,
2
] |
NCT03153410
|
33:44:chronic_disease,59:67:treatment,92:117:chronic_disease
|
Has history of (non-infectious) pneumonitis that required steroids, history or evidence of interstitial lung disease or active, non-infectious pneumonitis
| 1
|
[
"Has",
"history",
"of",
"(",
"non-infectious",
")",
"pneumonitis",
"that",
"required",
"steroids",
",",
"history",
"or",
"evidence",
"of",
"interstitial",
"lung",
"disease",
"or",
"active",
",",
"non-infectious",
"pneumonitis"
] |
[
0,
0,
0,
0,
0,
0,
2,
0,
0,
1,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02374333
|
14:30:chronic_disease
|
Uncontrolled active infection
| 1
|
[
"Uncontrolled",
"active",
"infection"
] |
[
0,
2,
2
] |
NCT02762266
|
107:111:treatment
|
Radiographic evidence of persistent, progressive, or recurrent disease in an area previously treated with TACE
| 1
|
[
"Radiographic",
"evidence",
"of",
"persistent",
",",
"progressive",
",",
"or",
"recurrent",
"disease",
"in",
"an",
"area",
"previously",
"treated",
"with",
"TACE"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02057133
|
29:46:treatment,126:148:chronic_disease,168:187:chronic_disease,189:200:chronic_disease,,
|
For Part G: Have a baseline electrocardiogram (obtained from Day -14 to Day -1) with any of the following abnormal findings: ventricular arrhythmia, evidence of acute myocardial ischemia, heart block (of any degree), or QTc prolongation (defined as QTcB ≥450 milliseconds)
| 1
|
[
"For",
"Part",
"G",
":",
"Have",
"a",
"baseline",
"electrocardiogram",
"(",
"obtained",
"from",
"Day",
"-14",
"to",
"Day",
"-1",
")",
"with",
"any",
"of",
"the",
"following",
"abnormal",
"findings",
":",
"ventricular",
"arrhythmia",
",",
"evidence",
"of",
"acute",
"myocardial",
"ischemia",
",",
"heart",
"block",
"(",
"of",
"any",
"degree",
")",
",",
"or",
"QTc",
"prolongation",
"(",
"defined",
"as",
"QTcB",
"≥450",
"milliseconds",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02624258
|
1:38:treatment,
|
Anti-CD20 monoclonal antibody therapy within the last 3 months, or absence of circulating B cells
| 1
|
[
"Anti-CD20",
"monoclonal",
"antibody",
"therapy",
"within",
"the",
"last",
"3",
"months",
",",
"or",
"absence",
"of",
"circulating",
"B",
"cells"
] |
[
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03153969
|
38:56:treatment
|
Teeth that are non-vital or have had root canal therapy
| 1
|
[
"Teeth",
"that",
"are",
"non-vital",
"or",
"have",
"had",
"root",
"canal",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02496611
|
1:16:chronic_disease
|
Bulimia nervosa
| 1
|
[
"Bulimia",
"nervosa"
] |
[
2,
2
] |
NCT02426047
|
1:15:chronic_disease
|
Kidney disease
| 1
|
[
"Kidney",
"disease"
] |
[
2,
2
] |
NCT01614197
|
1:9:cancer
|
Leukemia
| 1
|
[
"Leukemia"
] |
[
3
] |
NCT02321501
|
33:48:treatment
|
Unstable or increasing doses of corticosteroids
| 1
|
[
"Unstable",
"or",
"increasing",
"doses",
"of",
"corticosteroids"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT02639065
|
1:39:treatment,24:38:treatment,43:67:treatment,,129:139:treatment
|
intranasal and inhaled corticosteroids or systemic corticosteroids at physiological doses, which are not to exceed 10 mg/day of prednisone, or an equivalent corticosteroid
| 1
|
[
"intranasal",
"and",
"inhaled",
"corticosteroids",
"or",
"systemic",
"corticosteroids",
"at",
"physiological",
"doses",
",",
"which",
"are",
"not",
"to",
"exceed",
"10",
"mg/day",
"of",
"prednisone",
",",
"or",
"an",
"equivalent",
"corticosteroid"
] |
[
1,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1
] |
NCT02877394
|
16:33:treatment
|
Current use of opioid analgesics
| 1
|
[
"Current",
"use",
"of",
"opioid",
"analgesics"
] |
[
0,
0,
0,
1,
1
] |
NCT01705119
|
8:30:chronic_disease
|
Active gastrointestinal blood loss
| 1
|
[
"Active",
"gastrointestinal",
"blood",
"loss"
] |
[
0,
2,
2,
0
] |
NCT02518594
|
29:46:chronic_disease,48:51:chronic_disease,178:197:treatment,198:202:treatment,203:207:treatment
|
Specifically, patients with seizure disorders, HIV, and other medical conditions not specifically associated with an increased risk of indicated preterm birth are not excluded. Prior cervical cone/LOOP/LEEP
| 1
|
[
"Specifically",
",",
"patients",
"with",
"seizure",
"disorders",
",",
"HIV",
",",
"and",
"other",
"medical",
"conditions",
"not",
"specifically",
"associated",
"with",
"an",
"increased",
"risk",
"of",
"indicated",
"preterm",
"birth",
"are",
"not",
"excluded",
".",
"Prior",
"cervical",
"cone/LOOP/LEEP"
] |
[
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02541903
|
7:10:chronic_disease
|
known HIV carrier
| 1
|
[
"known",
"HIV",
"carrier"
] |
[
0,
2,
0
] |
NCT02225548
|
27:37:cancer,,74:82:cancer,86:108:cancer
|
Subject with a history of malignancy within the past 5 years (other than squamous or basal cell skin cancer)
| 1
|
[
"Subject",
"with",
"a",
"history",
"of",
"malignancy",
"within",
"the",
"past",
"5",
"years",
"(",
"other",
"than",
"squamous",
"or",
"basal",
"cell",
"skin",
"cancer",
")"
] |
[
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
3,
0
] |
NCT02100891
|
1:41:cancer
|
Diffuse intrinsic pontine gliomas (DIPG) are excluded
| 1
|
[
"Diffuse",
"intrinsic",
"pontine",
"gliomas",
"(",
"DIPG",
")",
"are",
"excluded"
] |
[
3,
3,
3,
3,
3,
0,
0,
0,
0
] |
NCT02227199
|
54:66:treatment
|
Patients must be anticipated to complete 2 cycles of chemotherapy
| 1
|
[
"Patients",
"must",
"be",
"anticipated",
"to",
"complete",
"2",
"cycles",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03096418
|
33:68:treatment
|
Patients must be candidates for neoadjuvant paclitaxel chemotherapy by their treating oncologist
| 1
|
[
"Patients",
"must",
"be",
"candidates",
"for",
"neoadjuvant",
"paclitaxel",
"chemotherapy",
"by",
"their",
"treating",
"oncologist"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0
] |
NCT02474667
|
21:49:chronic_disease
|
History of positive human immunodeficiency virus test
| 1
|
[
"History",
"of",
"positive",
"human",
"immunodeficiency",
"virus",
"test"
] |
[
0,
0,
0,
2,
2,
2,
0
] |
NCT03068780
|
1:20:chronic_disease
|
dystrophic EB (DEB)
| 1
|
[
"dystrophic",
"EB",
"(",
"DEB",
")"
] |
[
2,
2,
2,
0,
0
] |
NCT02394028
|
1:17:treatment,
|
anti-TNF therapy within 5 years from screening
| 1
|
[
"anti-TNF",
"therapy",
"within",
"5",
"years",
"from",
"screening"
] |
[
1,
1,
0,
0,
0,
0,
0
] |
NCT02424968
|
24:42:cancer,72:75:treatment,80:83:treatment,119:140:treatment,163:166:cancer,168:198:cancer,200:232:cancer,234:237:cancer,239:254:cancer,252:254:cancer
|
Must have a myeloid or lymphoid malignant disease that is treated with TLI and ATG reduced intensity conditioning for allogeneic transplant (any of the following AML, myelodysplastic syndrome [MDS], myeloproliferative disease [MPD], CLL, B or T-cell NHL, HL)
| 1
|
[
"Must",
"have",
"a",
"myeloid",
"or",
"lymphoid",
"malignant",
"disease",
"that",
"is",
"treated",
"with",
"TLI",
"and",
"ATG",
"reduced",
"intensity",
"conditioning",
"for",
"allogeneic",
"transplant",
"(",
"any",
"of",
"the",
"following",
"AML",
",",
"myelodysplastic",
"syndrome",
"[",
"MDS",
"]",
",",
"myeloproliferative",
"disease",
"[",
"MPD",
"]",
",",
"CLL",
",",
"B",
"or",
"T-cell",
"NHL",
",",
"HL",
")"
] |
[
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
3,
0,
3,
3,
3,
3,
0,
3,
0
] |
NCT02500407
|
1:19:chronic_disease,61:75:chronic_disease,93:124:chronic_disease,129:145:chronic_disease
|
Autoimmune disease with the exception of controlled/treated hypothyroidism, disease-related immune thrombocytopenic purpura, or hemolytic anemia
| 1
|
[
"Autoimmune",
"disease",
"with",
"the",
"exception",
"of",
"controlled/treated",
"hypothyroidism",
",",
"disease-related",
"immune",
"thrombocytopenic",
"purpura",
",",
"or",
"hemolytic",
"anemia"
] |
[
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
2,
2,
2,
0,
0,
2,
2
] |
NCT03137771
|
31:49:cancer,,,107:112:cancer,136:146:cancer
|
patients newly diagnosed with metastatic disease or those initially diagnosed and treated for stage I-III NSCLC who ultimately develop metastases
| 1
|
[
"patients",
"newly",
"diagnosed",
"with",
"metastatic",
"disease",
"or",
"those",
"initially",
"diagnosed",
"and",
"treated",
"for",
"stage",
"I-III",
"NSCLC",
"who",
"ultimately",
"develop",
"metastases"
] |
[
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
3
] |
NCT01494662
|
50:60:cancer
|
Individuals with a history of a different active malignancy
| 1
|
[
"Individuals",
"with",
"a",
"history",
"of",
"a",
"different",
"active",
"malignancy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02437370
|
20:36:chronic_disease,53:77:treatment,99:124:treatment,,152:181:treatment
|
Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to the first dose of trial treatment
| 1
|
[
"Has",
"a",
"diagnosis",
"of",
"immunodeficiency",
"or",
"is",
"receiving",
"systemic",
"steroid",
"therapy",
"or",
"any",
"other",
"form",
"of",
"immunosuppressive",
"therapy",
"within",
"7",
"days",
"prior",
"to",
"the",
"first",
"dose",
"of",
"trial",
"treatment"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT02555189
|
13:57:chronic_disease,61:71:chronic_disease,123:134:treatment,142:161:chronic_disease,194:202:chronic_disease,204:226:chronic_disease,231:252:chronic_disease
|
Patient has impairment of gastrointestinal (GI) function or GI disease that may significantly alter the absorption of the study drugs (e.g., ulcerative diseases, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome, or small bowel resection)
| 1
|
[
"Patient",
"has",
"impairment",
"of",
"gastrointestinal",
"(",
"GI",
")",
"function",
"or",
"GI",
"disease",
"that",
"may",
"significantly",
"alter",
"the",
"absorption",
"of",
"the",
"study",
"drugs",
"(",
"e.g.",
",",
"ulcerative",
"diseases",
",",
"uncontrolled",
"nausea",
",",
"vomiting",
",",
"diarrhea",
",",
"malabsorption",
"syndrome",
",",
"or",
"small",
"bowel",
"resection",
")"
] |
[
0,
0,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0
] |
NCT01884740
|
1:18:cancer
|
oligodendroglioma
| 1
|
[
"oligodendroglioma"
] |
[
3
] |
NCT02312596
|
,,88:97:treatment
|
Greater than 30% reduction in wound size during the first two weeks of observation and treatment by the investigator
| 1
|
[
"Greater",
"than",
"30",
"%",
"reduction",
"in",
"wound",
"size",
"during",
"the",
"first",
"two",
"weeks",
"of",
"observation",
"and",
"treatment",
"by",
"the",
"investigator"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02655692
|
12:30:chronic_disease
|
history of severe head injury
| 1
|
[
"history",
"of",
"severe",
"head",
"injury"
] |
[
0,
0,
2,
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.